Proteomics Market Expected to Reach $161.9 Billion by 2035

According to a new report published by Allied Market Research, titled, “Proteomics Market," The proteomics market was valued at $32.8 billion in 2023, and is estimated to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035. In addition, Asia-Pacific is expected to register fastest growth in the forecast period owing to development of pharmaceutical and biotechnology industry in the region and high adoption of the proteomics for new drug development. 

Proteomics is the study of the complete set of proteins present in a biological system, offering valuable insights into cellular functions, interactions, and disease mechanisms. In the healthcare industry, proteomics has emerged as a powerful tool for biomarker discovery, drug development, and personalized medicine. By analyzing protein profiles in tissues, blood, or other bodily fluids, proteomics enables the identification of disease markers for early diagnosis and prognosis assessment. Additionally, it facilitates the development of targeted therapies by understanding the underlying molecular pathways involved in various diseases.

The proteomics market size is expected to grow significantly owing to the high adoption of proteomics for disease diagnosis and rise in use of proteomics for drug discovery and development. Over recent years, proteomics, the study of proteins and their functions within biological systems, has witnessed remarkable advancements in technology and methodology. This has significantly enhanced its potential applications in disease diagnosis. One of the primary reasons for its increasing adoption is its ability to provide a comprehensive understanding of the molecular mechanisms underlying diseases. By analyzing the abundance, structure, interactions, and modifications of proteins, proteomics enables researchers and clinicians to unravel intricate disease pathways and identify potential biomarkers indicative of disease states.

According to a 2023 article by National Library of Medicine, it was reported that proteomics methods hold considerable potential for the identification of novel biomarkers that could serve as the foundation to understand physiological and pathophysiological processes in human body. This deeper insight allows for more accurate and personalized diagnoses, aiding in the early detection and treatment of various diseases, including cancer, cardiovascular disorders, neurological conditions, and infectious diseases. Additionally, the advent of high-throughput proteomic techniques, such as mass spectrometry and protein microarrays, has streamlined the process of biomarker discovery and validation, making proteomic analysis more accessible and cost-effective. Thus, according to proteomics market analysis the rise in the adoption of the proteomics for disease diagnosis is expected to drive the growth of the market.

According to proteomics market trends analysis, rise in the use of proteomics for drug discovery and development is expected to drive the growth of the market. This trend is underpinned by the recognition of proteins as pivotal players in biological processes and disease mechanisms. Proteomics offers a comprehensive approach to studying the entire complement of proteins within a cell, tissue, or organism, providing insights into their structure, function, interactions, and modifications. With the advent of advanced technologies such as mass spectrometry, protein microarrays, and bioinformatics tools, researchers can now analyze complex protein mixtures with unprecedented depth and accuracy.

Proteomics offers a comprehensive approach to studying the entire complement of proteins within a cell, tissue, or organism, providing insights into their structure, function, interactions, and modifications. With the advent of advanced technologies such as mass spectrometry, protein microarrays, and bioinformatics tools, researchers can now analyze complex protein mixtures with unprecedented depth and accuracy. This capability is particularly crucial in drug discovery, where understanding the proteome landscape of diseased tissues can uncover novel therapeutic targets and biomarkers for various conditions, including cancer, neurodegenerative disorders, and infectious diseases. Additionally, proteomics facilitates the elucidation of drug-protein interactions, aiding in the optimization of drug candidates for enhanced efficacy and reduced toxicity. 

Moreover, according to proteomics market forecast analysis the integration of proteomic data with other omics datasets, such as genomics and transcriptomics, enables a holistic understanding of biological systems, paving the way for personalized medicine and precision therapeutics. According to the 2021 report by the National Library of Medicine, it was reported that proteomics is a revolutionary technique that has been used in medicine, including drug and biomarker discovery. Proteomics can identify and monitor biomarkers by analyzing the proteins in the body fluids such as urine, serum, exhaled breath and spinal fluid. Proteomics can also facilitate drug development by providing a comprehensive map of protein interactions associated with disease pathways. As pharmaceutical companies increasingly recognize the value of proteomics in accelerating drug development pipelines and improving clinical outcomes, investments in proteomic technologies and collaborations with academic institutions and biotechnology firms are on the rise, further fueling the expansion of the proteomics market.

The proteomics industry is segmented on the basis of component, application, and region. By component, the market is divided into reagents, instruments and services. By application, the market is divided into drug discovery, diseases diagnosis, and other. By component, the market is classified into card reagents, instruments and services. The reagent segment dominated the proteomics market share in 2023. This is attributed high use of reagents in drug discover and disease diagnosis using proteomics. Reagents are crucial components in various proteomic experimental procedures. They are used in sample preparation, protein separation, quantification, and analysis. As proteomics research becomes more sophisticated and diverse, the demand for specialized reagents tailored to different experimental needs increases.

By application, the proteomics industry is classified into drug discovery, diseases diagnosis, and other. The drug discovery segment dominated the proteomics market in 2023. This is attributed high adoption of proteomics study to evaluate safety profile and toxicology study of the new drug candidate. Proteomics plays a pivotal role in the development of personalized medicine. By analyzing proteomic data, researchers can tailor treatments to the unique molecular profiles of patients, maximizing therapeutic outcomes while minimizing adverse effects. This personalized approach increases the demand for proteomic technologies and services in drug discovery and development.

On the basis of region, North America accounted for largest share in 2023 and is expected to remain dominant during the forecast period, owing to well-established healthcare infrastructure and rise in prevalence of chronic diseases.  However, Asia-Pacific is anticipated to witness notable growth, owing to developing pharmaceutical industries in the region. 

Key Findings of the Study   

• On the basis of component, the reagent segment dominated the proteomics market share in terms of revenue in 2023. 
• On the basis of application, the drug discovery segment dominated the market in terms of revenue in 2023. 
• On the basis of region, North America dominated the proteomics market size in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.